Skip to main content
Top
Published in: Digestive Diseases and Sciences 3/2011

01-03-2011 | Stanford Multidisciplinary Seminars

Relapse of Intestinal and Hepatic Amebiasis After Treatment

Authors: Elizabeth W. Hwang, Lawrence Cheung, Amirkaveh Mojtahed, Christine A. Cartwright

Published in: Digestive Diseases and Sciences | Issue 3/2011

Login to get access

Excerpt

Six months after returning from a trip to Hawaii, a previously healthy 63-year-old man presented with 5 months of right upper-quadrant abdominal pain and non-bloody diarrhea, 3 months of nausea and non-bloody vomiting, and 1 month of fevers, chills, night sweats, and anorexia, culminating in a loss of 20 lbs. Comprehensive laboratory tests were notable for leukocytosis with a white blood cell (WBC) count of 11,300/mm3 with 88% neutrophils, elevated liver chemistry tests (total bilirubin 0.6 mg/dl, aspartate aminotransferase [AST] 64 U/l, alanine aminotransferase [ALT] 92 U/l, and alkaline phosphatase 674 U/l), and renal failure (blood urea nitrogen 57 mg/dl, creatinine 2.3 mg/dl). Due to his renal insufficiency, non-contrast imaging of the abdomen was obtained, which revealed a 12-cm, thick-walled, multiloculated cystic lesion in the right lobe of the liver (Fig. 1a). Cultures obtained from the patient’s blood, stool, and fluid aspirated from the liver abscess remained sterile. However, serum antibodies to Entamoeba histolytica were positive at a titer of 1:128.
Literature
2.
go back to reference Bercu TE, Petri WA, Behm BW. Amebic colitis: New insights into pathogenesis and treatment. Curr Gastroenterol Rep. 2007;9:429–433.CrossRefPubMed Bercu TE, Petri WA, Behm BW. Amebic colitis: New insights into pathogenesis and treatment. Curr Gastroenterol Rep. 2007;9:429–433.CrossRefPubMed
4.
go back to reference WHO/PAHO/UNESCO report. A consultation with experts on amoebiasis. Mexico City, Mexico 28–29 January, 1997. Epidemiol Bull. 1997;18:13–14. WHO/PAHO/UNESCO report. A consultation with experts on amoebiasis. Mexico City, Mexico 28–29 January, 1997. Epidemiol Bull. 1997;18:13–14.
5.
go back to reference Haque R, Huston CD, Hughes M, Houpt E, Petri WA. Amebiasis. N Eng J Med. 2003;348:1565–1573.CrossRef Haque R, Huston CD, Hughes M, Houpt E, Petri WA. Amebiasis. N Eng J Med. 2003;348:1565–1573.CrossRef
6.
7.
go back to reference Khokhani RC, Garud AD, Deodhar KP, Sureka SB, Juljarni M, Damle VB. Treatment of amoebic liver abscess with tinidazole and metronidazole. Drugs. 1978;15:23–25.CrossRefPubMed Khokhani RC, Garud AD, Deodhar KP, Sureka SB, Juljarni M, Damle VB. Treatment of amoebic liver abscess with tinidazole and metronidazole. Drugs. 1978;15:23–25.CrossRefPubMed
9.
go back to reference Rossignol JF, Kabil SM, El-Gohary Y, Younis AM. Nitazoxanide in the treatment of amoebiasis. Trans R Soc Trop Med Hyg. 2007;101:1025–1031.CrossRefPubMed Rossignol JF, Kabil SM, El-Gohary Y, Younis AM. Nitazoxanide in the treatment of amoebiasis. Trans R Soc Trop Med Hyg. 2007;101:1025–1031.CrossRefPubMed
10.
go back to reference Bansal D, Sehgal R, Chawla Y, Malla N, Mahajan RC. Multidrug resistance in amoebiasis patients. Indian J Med Res. 2006;124:189–194.PubMed Bansal D, Sehgal R, Chawla Y, Malla N, Mahajan RC. Multidrug resistance in amoebiasis patients. Indian J Med Res. 2006;124:189–194.PubMed
11.
go back to reference Freeman O, Akamanguna A, Jarikre LN. Amoebic liver abscess: The effect of aspiration on the resolution or healing time. Ann Trop Med Parasitol. 1990;84:281–287.PubMed Freeman O, Akamanguna A, Jarikre LN. Amoebic liver abscess: The effect of aspiration on the resolution or healing time. Ann Trop Med Parasitol. 1990;84:281–287.PubMed
Metadata
Title
Relapse of Intestinal and Hepatic Amebiasis After Treatment
Authors
Elizabeth W. Hwang
Lawrence Cheung
Amirkaveh Mojtahed
Christine A. Cartwright
Publication date
01-03-2011
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 3/2011
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-010-1492-y

Other articles of this Issue 3/2011

Digestive Diseases and Sciences 3/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine